On February 17, 2023 Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") reported an update to its previously issued "Frequently Asked Questions" document under the "Investors" section of its website at www.sorrentotherapeutics.com regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company previously held by Sorrento (the "Dividend Stock") (Press release, Sorrento Therapeutics, FEB 17, 2023, View Sourcenews-releases/news-release-details/sorrento-issues-update-its-previously-issued-faq-regarding" target="_blank" title="View Sourcenews-releases/news-release-details/sorrento-issues-update-its-previously-issued-faq-regarding" rel="nofollow">View Source [SID1234627386]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The update to the FAQs provides notice regarding the no lien code added on Scilex (Nasdaq: SCLX) common stock that was distributed as a dividend to Sorrento’s stockholders and provides notice to brokerage firms, banks, dealers and similar organizations listed therein that a dividend confirmation had previously been distributed to such firms by Scilex’s transfer agent (the "Dividend Confirmation"). The update further requests that such firms contact Scilex’s transfer agent if they have not received the confirmation. The update to the FAQs and related annex are included in this press release and can also be found at View Source
NOTICE OF ADDITIONAL RESTRICTION CODE V050I BY CONTINENTAL STOCK TRANSFER & TRUST COMPANY
Effective as of February 17, 2023, Continental Stock Transfer & Trust Company has added the "No Lien Code V505I" that it had previously imposed on the Dividend Stock. Any shares of Dividend Stock held by your brokerage firm, bank, dealer or other similar organization for your benefit now bear only Scilex’s CUSIP number, which is 80880W106. If you are entitled to receive Dividend Stock, please contact your brokerage firm, bank, or other similar organization immediately to confirm that the CUSIP number appears on your brokerage statement with respect to your Dividend Stock.
RESTRICTION CODE V050I
THE SECURITIES ARE NOT SUBJECT TO ANY RIGHT, CHARGE, SECURITY INTEREST, LIEN OR CLAIM OF ANY KIND IN FAVOR OF CONTINENTAL STOCK TRANSFER & TRUST COMPANY ("CONTINENTAL") OR ANY PERSON CLAIMING THROUGH CONTINENTAL AND IF, NOTWITHSTANDING THE FOREGOING, THE SECURITIES BECOME SUBJECT TO ANY SUCH RIGHT, CHARGE, SECURITY INTEREST, LIEN, OR CLAIM OF ANY KIND, YOU WILL BE PROMPTLY NOTIFIED.
NOTICE TO BROKERAGE FIRMS, BANKS, DEALERS AND OTHER SIMILAR ORGANIZATIONS
If your firm, bank or similar organization has not received the Dividend Confirmation that was mailed and emailed to your firm, bank or similar organization, please contact Scilex’s transfer agent immediately to obtain a copy of the Dividend Confirmation.